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Zinc oxide nanoparticles were synthesized in order to get biologically active additive for correction of 
zinc-deficiency states. Nanosized zinc oxide was derived by through condensation method from zinc acetate 
and lithium hydroxide dissolved in dehydrated alcohol. Resulted particles were examined through method 
of small-angle X-ray scattering. Measurement results confirm presence of nanoparticles with average size 
about 2 nm. 
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A certain microelement balance must be supported 
within the organism for normal behavior of vital pro-
cesses. Zinc may be marked among dozens of other es-
sential microelements. Zn2 + is included in the structure 
of active centers of more than 100 metalloenzymes, 
provides healthy state of thymus and immunity, affects 
growth / aging of neurons and neurotransmitter syn-
thesis, plays a key role in generation of normal sexual 
function of men [1]. 
Light or moderate deficiency of zinc comes out in 
immunity decrease and liability to contagious and non-
contagious diseases: ischemic heart disease, atheroscle-
rosis, diabetes mellitus and some others. Serious zinc 
deficiency of pregnant women may cause congenital mal-
formations [1]. More than 2 billion people around the 
world do not get enough zinc from their ration. Zink de-
ficiency is an important health protection issue in ad-
vanced countries. According to figures from the Interna-
tional Zinc Association, zinc-deficiency states are regis-
tered almost everywhere. Moderate hypozincosis is 
widespread in Europe, Brazil; serious zinc deficiencies 
are registered in India, South Africa. Zink deficiency 
cases occur among population of Russia as well [1, 2]. 
Various zinc-containing biologically active additives 
may be used for correction of moderate zinc-deficiency 
states. Different preparations for hypozincosis correc-
tion are represented in the pharmaceutical market. 
Despite their widespread distribution, such prepara-
tions can not provide optimal bioavailability of zinc, 
concentrations of Zn2 + are extremely high. 
All traditional pharmaceutical forms have a set of 
fundamental defects: excessive medicinal substance 
consumption, undirected operation of medical sub-
stance, insufficient biocompatibility and bioavailability. 
The march of modern science allows creating brand 
new pharmaceutical forms without defects listed above. 
Their improved properties can be attributed to size 
reduction. Nanosized medicinal particles have series of 
advantages: increased bioavailability, provision of op-
timal dosage, minimization of side effects, etc. [1]. 
 
The purpose of this research was to derive and 
identify nanoparticles of zinc oxide that are proposed to 
be used as the general component of preparation for 
zinc-deficiency correction. 
Synthesis of nanoparticles was carried out through 
condensation method in the environment of dehydrated 
ethanol. Rectified ethanol with 99.6 % concentration 
was dehydrated through boiling with calcium metal 
during 3 hours and further distillation. 
For derivation of nanoparticles, 0.15 g of lithium 
hydroxide and 0.55 g of zinc acetate were dissolved in 
50 ml of dehydrated alcohol during 15 minutes at con-
tinuous stirring with magnetic mixer. Zinc acetate was 
dissolved at the boiling temperature. After dissolution, 
lithium hydroxide and zinc acetate solutions were 
cooled to 0 С at continuous stirring. After that, zinc 
acetate solution was added to another solution at a 
speed of several drops per second. The solution was 
heated to the room temperature; after that, 60 ml of 
deionized water were added to it. The resulted suspen-
sion was centrifuged. The resulted precipitation was 
dried during 12 hours under vacuum at 90 С and re-
dried for 3 hours in desiccator at 120 С. 
 
 
 
Fig. 1 – Distribution curve by dimensions for zinc oxide nano-
particles according to small-angle X-ray scattering data 
r, nm 
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The method of small-angle X-ray scattering was 
used for identification of zinc oxide nanoparticles. 
Measurement was carried out by means of small-angle 
X-ray scattering installation SAXSess mc2 from Anton 
Paar, Austria. During measurement process, vacuum 
with pressure of about 0.3 mbar is created in the sam-
ple chamber. The installation was set to X-ray wave-
length () of 0.1542 nm. Functions of volume distribu-
tion of nanoparticles by DV(r) dimensions were calcu-
lated on the computer according to small-angle scatter-
ing intensity curves. Computer processing of experi-
ment data was carried out with the use of GNOM soft-
ware. As shown in the figure below, the majority (near-
ly 80 %) of particles contained in the gel is represented 
in size of about 2 nm. Larger aggregates are also met – 
12 nm, 22 nm and 38 nm. 
Therefore, zinc oxide nanoparticles with size of 
about 2 nm were successfully derived as the result of 
the experiment. Such particles may be used as active 
ingredient in a preparation for correction of zinc defi-
ciency. 
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